Evidence map›Paper›PMID 20237794›Full record

ArticleHistochemistry and cell biology2010

Human LPLUNC1 is a secreted product of goblet cells and minor glands of the respiratory and upper aerodigestive tracts.

Colin D Bingle, Kirsty Wilson, Hayley Lunn, Frances A Barnes, Alec S High, William A Wallace, Doris Rassl, Michael A Campos, Manuel Ribeiro, Lynne Bingle

Open access · hybridAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Subversion of a family of antimicrobial proteins byFrontiers in cellular and infection microbiology · 2024
    Article
  5. BPIFB1 loss alters airway mucus properties and diminishes mucociliary clearance.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  6. BPIFA1 is a secreted biomarker of differentiating human airway epithelium.Frontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. Molecular biology of BPIFB1 and its advances in disease.Annals of translational medicine · 2020
    Review
  9. Association of innate defense proteins BPIFA1 and BPIFB1 with disease severity in COPD.International journal of chronic obstructive pulmonary disease · 2018
    Article
  10. Identification ofGenetics · 2017
    Article
  11. Assessment ofVeterinary medicine international · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Colin D BingleAcademic Unit of Respiratory Medicine, Department of Infection and Immunity, University of Sheffield, Sheffield, S10 2JF, UK. c.d.bingle@sheffield.ac.uk
Kirsty Wilson
Hayley Lunn
Frances A Barnes
Alec S High
William A Wallace
Doris Rassl
Michael A Campos
Manuel Ribeiro
Lynne Bingle
University of Sheffield · GBUniversity of Miami · USPapworth Hospital · GBUniversity of Edinburgh · GBUniversity of Leeds · GB

Funding

Wellcome Trust 076491
6 · The paper itself

Abstract

Long PLUNC1 (LPLUNC1, C20orf114) is a member of a family of poorly described proteins (PLUNCS) expressed in the upper respiratory tract and oral cavity, which may function in host defence. Although it is one of the most highly expressed genes in the upper airways and has been identified in sputum and nasal secretions by proteomic studies, localisation of LPLUNC1 protein has not yet been described. We developed affinity purified antibodies and localised the protein in tissues of the human respiratory tract, oro- and nasopharynx. We have complemented these studies with analysis of LPLUNC1 expression in primary human lung cell cultures and used Western blotting to study the protein in cell culture secretions and in BAL. LPLUNC1 is a product of a population of goblet cells in the airway epithelium and nasal passages and is also present in airway submucosal glands and minor glands of the oral and nasal cavities. The protein is not expressed in peripheral lung epithelial cells. LPLUNC1 is present in bronchoalveolar lavage fluid as two glycosylated isoforms and primary airway epithelial cells produce identical proteins as they undergo mucociliary differentiation. Our results suggest that LPLUNC1 is an abundant, secreted product of goblet cells and minor mucosal glands of the respiratory tract and oral cavity and suggest that the protein functions in the complex milieu that protects the mucosal surfaces in these locations.

Indexed as

AntibodiesBronchoalveolar Lavage FluidCell DifferentiationCells, CulturedElafinEpithelial CellsExocrine GlandsGene ExpressionGlycoproteinsGlycosylationGoblet CellsHumansMouthMucin 5ACPalatine TonsilPhosphoproteinsAntibodiesBPIFA1 protein, humanElafinGlycoproteinsMUC5AC protein, humanMucin 5ACPhosphoproteinsPI3 protein, humanSCGB1A1 protein, humanSecretory Leukocyte Peptidase InhibitorSLPI protein, humanUteroglobin

Identifiers

PMID20237794
PMCPMC2852594
OpenAlexW1976352956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.